Benitec Biopharma Inc. Annual Depreciation in USD from 2019 to 2022

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Benitec Biopharma Inc. quarterly/annual Depreciation history and growth rate from 2019 to 2022.
  • Benitec Biopharma Inc. Depreciation for the quarter ending September 30, 2023 was $19K, a 54.8% decline year-over-year.
  • Benitec Biopharma Inc. annual Depreciation for 2022 was $167K, a 27.7% decline from 2021.
  • Benitec Biopharma Inc. annual Depreciation for 2021 was $231K, a 413% increase from 2020.
  • Benitec Biopharma Inc. annual Depreciation for 2020 was $45K, a 71.5% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $167K -$64K -27.7% Jul 1, 2021 Jun 30, 2022 10-K 2022-09-02
2021 $231K +$186K +413% Jul 1, 2020 Jun 30, 2021 10-K 2022-09-02
2020 $45K -$113K -71.5% Jul 1, 2019 Jun 30, 2020 10-Q 2021-11-15
2019 $158K Jul 1, 2018 Jun 30, 2019 10-K 2020-09-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.